Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader…
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
February 28, 2025 02:42 ET | Source: Nxera Pharma Daridorexant is a…
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025 19:05 ET | Source: Nxera Pharma Cenerimod is a…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, the…
TraceLink Named a Top 10 Pharma and Life Sciences Technology Solution Provider by CIOTechOutlook
BOSTON, Jan. 29, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network…
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258
SAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
January 23, 2025 18:41 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE,…
Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones
PANAJI, India, Jan. 10, 2025 /PRNewswire/ -- Zlata Pharma LLP hosted a…
Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones
PANAJI, India, Jan. 10, 2025 /PRNewswire/ -- Zlata Pharma LLP hosted a…